Export

EN
FR
Plazomicin
Essential medicine status
General description
Plazomicin is a next-generation aminoglycoside ("neoglycoside") used in the treatment of multi-drug resistant infections caused by carbapenem resistant Enterobacteriaceae, carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii.
INN
Plazomicin
Medicine type
Chemical agent
Antibiotic groups
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Reserve group antibiotics
  • Parenteral > General injections > IV: 500 mg per 10 mL (Injection)